An Exploratory Analysis of Alendronate in Older Men with Low Glomerular Filtration Rate
Journal of Aging & Pharmacotherapy · 2006
DOI: 10.3109/j397v13n02_03 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Aging & Pharmacotherapy, 2006. Verfasst von K. E. Hansen und 7 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Bisphosphonates are not recommended for patients with a creatinine clearance less than 35 ml/minute, yet many individuals with osteoporosis have reduced renal function. We performed a retrospective case-control study to explore the effects of alendronate on bone mass in such individuals. Cases and controls had a mean glomerular filtration rate of 26 and 70 ml/minute, respectively, and mean age of 82 and 62 years, respectively. The change in bone mass at the spine, femur, and radius was similar between cases and controls (p > 0.05, all comparisons). A prospective clinical trial defining the role of bisphosphonate therapy among older individuals with renal disease is warranted.
Zitieren
APA
Hansen, K. E., Hofmann, R. M., Drake, R. K., Argall, T. R., Bier, H. A., Grigg, K. T., Rouse, E. D., & Elliott, M. E. (2006). An Exploratory Analysis of Alendronate in Older Men with Low Glomerular Filtration Rate. Journal of Aging & Pharmacotherapy. https://doi.org/10.3109/j397v13n02_03
Vancouver
Hansen KE, Hofmann RM, Drake RK, Argall TR, Bier HA, Grigg KT, et al. An Exploratory Analysis of Alendronate in Older Men with Low Glomerular Filtration Rate. Journal of Aging & Pharmacotherapy. 2006. doi:10.3109/j397v13n02_03
BibTeX
@article{Hansen2006,
author = {Hansen, K. E. and Hofmann, R. M. and Drake, R. K. and Argall, T. R. and Bier, H. A. and Grigg, K. T. and Rouse, E. D. and Elliott, M. E.},
title = {An Exploratory Analysis of Alendronate in Older Men with Low Glomerular Filtration Rate},
journal = {Journal of Aging & Pharmacotherapy},
year = {2006},
doi = {10.3109/j397v13n02_03}
}
EUVIMED